David M. Stack - Mar 24, 2021 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Mar 24, 2021
Transactions value $
-$2,151,873
Form type
4
Date filed
5/13/2021, 06:01 PM
Next filing
Jun 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Gift $0 -1.08K -1.1% $0.00 97.3K Mar 24, 2021 By Three Colleens Investment, LLC F1
transaction PCRX Common Stock Options Exercise $230K +21.3K +27.94% $10.81 97.3K May 11, 2021 Direct F2
transaction PCRX Common Stock Sale -$809K -13.3K -13.69% $60.78 84K May 11, 2021 Direct F2, F3
transaction PCRX Common Stock Sale -$485K -7.93K -9.44% $61.19 76.1K May 11, 2021 Direct F2, F4
transaction PCRX Common Stock Options Exercise $230K +21.3K +27.94% $10.81 97.3K May 12, 2021 Direct F2
transaction PCRX Common Stock Sale -$180K -2.97K -3.05% $60.76 94.3K May 12, 2021 Direct F2, F5
transaction PCRX Common Stock Sale -$911K -14.7K -15.55% $62.08 79.7K May 12, 2021 Direct F2, F6
transaction PCRX Common Stock Sale -$225K -3.61K -4.53% $62.41 76.1K May 12, 2021 Direct F2, F7
holding PCRX Common Stock 18.6K Mar 24, 2021 By Stack Schroon Mohawk FLP F1
holding PCRX Common Stock 315 Mar 24, 2021 By LCK Investment LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCRX Stock Option (Right to Buy) Options Exercise $0 -21.3K -16.2% $0.00 110K May 11, 2021 Common Stock 21.3K $10.81 Direct F8
transaction PCRX Stock Option (Right to Buy) Options Exercise $0 -21.3K -19.33% $0.00 88.7K May 12, 2021 Common Stock 21.3K $10.81 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Stack and his wife are the owners of each of Three Colleens Investment, LLC and LCK Investment LLC. Mr. Stack is the general partner of Stack Schroon Mohawk FLP.
F2 The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.995, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 7.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.68, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.33 to $61.31, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.355 to $62.35, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.355 to $62.595, inclusive.
F8 The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.